Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure

Objectives: To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, after Gemtuzumab ozogamicin administration, has never...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biology (Basel)
Auteurs principaux: Zaytsev, Daniil, Girshova, Larisa, Ivanov, Vladimir, Budaeva, Irina, Motorin, Dmitri, Badaev, Renat, Mirolubova, Julia, Grobovenko, Evgeni, Chitanava, Tamara, Zaykova, Ekaterina, Alexeeva, Julia, Zaritskey, Andrey
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7167863/
https://ncbi.nlm.nih.gov/pubmed/32050707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology9020028
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires